DENNIS MULROY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DENNIS MULROY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DENNIS MULROY. DENNIS MULROY is Chief Financial Officer in LA JOLLA PHARMACEUTICAL CO ($LJPC) and CFO in MOLECULAR IMAGING CORP ($MLRI.OB) and Chief Financial Officer in ANAPTYSBIO, INC ($ANAB).
Latest Insider Trading Transactions of DENNIS MULROY
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANAB, LJPC, MLRI.OB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2021 | ANAB | ANAPTYSBIO, INC | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 29.70 | 45,000 | 1,336,500 | 45,000 | |
| Jul 15 2020 | ANAB | ANAPTYSBIO, INC | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 20.16 | 90,600 | 1,826,496 | 90,600 | |
| Jun 02 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 4.72 | 82 | 387 | 82 | |
| Jun 02 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 4.01 | 82 | 329 | 5,067 | 5 K to 5.1 K (+1.64 %) |
| May 19 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.89 | 56 | 386 | 56 | |
| May 19 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.86 | 56 | 328 | 4,985 | 4.9 K to 5 K (+1.14 %) |
| May 04 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 7.26 | 53 | 385 | 53 | |
| May 04 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 6.17 | 53 | 327 | 4,929 | 4.9 K to 4.9 K (+1.09 %) |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.60 | 58 | 383 | 58 | |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.61 | 58 | 325 | 4,876 | 4.8 K to 4.9 K (+1.20 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Dec 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 3.35 | 112 | 375 | 112 | |
| Dec 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 2.85 | 112 | 319 | 4,802 | 4.7 K to 4.8 K (+2.39 %) |
| Dec 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 2.74 | 138 | 378 | 138 | |
| Dec 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 2.33 | 138 | 322 | 4,690 | 4.6 K to 4.7 K (+3.03 %) |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.02 | 62 | 373 | 62 | |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.12 | 62 | 317 | 4,552 | 4.5 K to 4.6 K (+1.38 %) |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 8.38 | 224 | 1,877 | 224 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.12 | 224 | 1,595 | 4,223 | 4 K to 4.2 K (+5.60 %) |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 8.80 | 213 | 1,874 | 213 | |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.48 | 213 | 1,593 | 3,999 | 3.8 K to 4 K (+5.63 %) |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 10.92 | 171 | 1,867 | 171 | |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 9.28 | 171 | 1,587 | 3,786 | 3.6 K to 3.8 K (+4.73 %) |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.57 | 196 | 1,876 | 196 | |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 8.13 | 196 | 1,593 | 3,615 | 3.4 K to 3.6 K (+5.73 %) |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.43 | 198 | 1,867 | 198 | |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 8.02 | 198 | 1,588 | 3,419 | 3.2 K to 3.4 K (+6.15 %) |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 8.36 | 224 | 1,873 | 224 | |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.11 | 224 | 1,593 | 3,221 | 3 K to 3.2 K (+7.47 %) |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.24 | 203 | 1,876 | 203 | |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.85 | 203 | 1,594 | 2,997 | 2.8 K to 3 K (+7.27 %) |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.25 | 202 | 1,869 | 202 | |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.86 | 202 | 1,588 | 2,794 | 2.6 K to 2.8 K (+7.79 %) |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.71 | 193 | 1,874 | 193 | |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 8.25 | 193 | 1,592 | 2,592 | 2.4 K to 2.6 K (+8.05 %) |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 5.39 | 347 | 1,870 | 347 | |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 4.58 | 347 | 1,589 | 2,399 | 2.1 K to 2.4 K (+16.91 %) |
| May 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.57 | 285 | 1,872 | 285 | |
| May 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.58 | 285 | 1,590 | 2,052 | 1.8 K to 2.1 K (+16.13 %) |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 8.05 | 233 | 1,876 | 233 | |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 6.84 | 233 | 1,594 | 1,767 | 1.5 K to 1.8 K (+15.19 %) |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 7.16 | 261 | 1,869 | 261 | |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 6.09 | 261 | 1,589 | 1,534 | 1.3 K to 1.5 K (+20.50 %) |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.43 | 59 | 379 | 59 | |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.47 | 59 | 323 | 1,273 | 1.2 K to 1.3 K (+4.86 %) |
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 7.64 | 49 | 374 | 49 | |
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 6.49 | 49 | 318 | 1,214 | 1.2 K to 1.2 K (+4.21 %) |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 5.70 | 65 | 371 | 65 | |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 4.85 | 65 | 315 | 1,165 | 1.1 K to 1.2 K (+5.91 %) |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.23 | 60 | 374 | 60 | |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.30 | 60 | 318 | 1,100 | 1 K to 1.1 K (+5.77 %) |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.04 | 63 | 381 | 63 | |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.13 | 63 | 323 | 1,040 | 977 to 1 K (+6.45 %) |
| Jan 25 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 5.99 | 53,000 | 317,470 | 53,000 | |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.75 | 316 | 2,133 | 316 | |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.74 | 316 | 1,814 | 977 | 661 to 977 (+47.81 %) |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.43 | 39 | 368 | 39 | |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 8.02 | 39 | 313 | 661 | 622 to 661 (+6.27 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 12.80 | 28 | 358 | 28 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 12.80 | 28 | 358 | 28 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 10.88 | 28 | 305 | 622 | 594 to 622 (+4.71 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 10.88 | 28 | 305 | 622 | 594 to 622 (+4.71 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 14.47 | 26 | 376 | 26 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 14.47 | 26 | 376 | 26 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 12.30 | 26 | 320 | 594 | 568 to 594 (+4.58 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 12.30 | 26 | 320 | 594 | 568 to 594 (+4.58 %) |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 14.90 | 24 | 358 | 24 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 12.67 | 24 | 304 | 568 | 544 to 568 (+4.41 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.30 | 22 | 359 | 22 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.30 | 22 | 359 | 22 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.86 | 22 | 305 | 544 | 522 to 544 (+4.21 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.86 | 22 | 305 | 544 | 522 to 544 (+4.21 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.25 | 22 | 358 | 22 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.25 | 22 | 358 | 22 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.81 | 22 | 304 | 522 | 500 to 522 (+4.40 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.81 | 22 | 304 | 522 | 500 to 522 (+4.40 %) |
| Dec 29 2017 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 32.47 | 6,700 | 217,549 | 6,700 | |
| Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 28.10 | 49,000 | 1,376,900 | 49,000 | |
| Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 19.19 | 64,100 | 1,230,079 | 64,100 | |
| Dec 23 2015 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 28.24 | 41,500 | 1,171,960 | 41,500 | |
| Apr 08 2015 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 18.23 | 60,000 | 1,093,800 | 60,000 | |
| Apr 16 2004 | MLRI.OB | MOLECULAR IMAGING ... | MULROY DENNIS | CFO | Option Exercise | A | 0.22 | 250,000 | 55,000 | 250,000 | |
| Apr 16 2004 | MLRI.OB | MOLECULAR IMAGING ... | MULROY DENNIS | CFO | Option Exercise | A | 0.22 | 250,000 | 55,000 | 250,000 |
Page: 1